On heels of Parkinson’s readout, Cerevance enters Alzheimer’s discovery deal with Merck

August 9, 2022

Pharma pays $25M up front to use target discovery platform as privately-held Cerevance plots path forward for wholly-owned clinical program


View the article 

All News & Insights